Sfoglia per Autore ZUCALI, PAOLO ANDREA
Can sentinel node biopsy avoid axillary dissection in clinically node-negative breast cancer patients?
1998-01-01 Galimberti, V.; Zurrida, S.; Zucali, P.; Luini, A.
Particle beam therapy (hadrontherapy): basis for interest and clinical experience
1998-01-01 Orecchia, R; Zurlo, A; Loasses, A; Krengli, M; Tosi, G; Zurrida, S; Zucali, P; Veronesi, U
Optimized sentinel node scintigraphy in breast cancer
1998-01-01 Paganelli, G; De Cicco, C; Cremonesi, M; Prisco, G; Calza, P; Luini, A; Zucali, P; Veronesi, U
[Combination of 5-Fluorouracil and folinic acid--is it still the standard therapy for advanced colorectal carcinoma?]
2000-01-01 Carnaghi, C; Zucali, P; Garassino, I
Is combination of 5-FU/FA still the standard therapy for the treatment of advance colorectal cancer?
2000-01-01 Carnaghi, C; Zucali, P; Garassino, I
Carcinoma del colon-retto
2001-01-01 Zucali, PAOLO ANDREA; Rimassa, Lorenza; Santoro, Armando
Carcinoma del pancreas
2001-01-01 Rimassa, Lorenza; Zucali, PAOLO ANDREA
Timing of breast cancer surgery in relation to the menstrual cycle: an update of developments
2001-01-01 Zurrida, Stefano; Galimberti, Viviana; Gibelli, Bianca; Luini, Alberto; Gianoglio, Simona; Sandri, Maria Teresa; Passerini, Rita; Maisonneuve, Patrick; Zucali, Paolo; Jeronesi, Giulia; Pigatto, Francesca; Veronesi, Umberto
Irinotecan and raltitrexed: an active combination in advanced colorectal cancer
2002-01-01 Carnaghi, C; Rimassa, L; Garassino, I; Zucali, Pa; Masci, G; Fallini, M; Morenghi, E; Santoro, A
Minidose warfarin is associated with a high incidence of International Normalized Ratio elevation during chemotherapy with FOLFOX regimen
2003-01-01 Magagnoli, M; Masci, G; Carnaghi, C; Zucali, Pa; Castagna, L; Morenghi, E; Santoro, A
Gefitinib ('Iressa', ZD1839) in elderly patients with progressive pretreated non-small-cell lung cancer: results from the Istituto Clinico Humanitas
2003-01-01 Parra, Hs; Cavina, R; Zucali, P; Campagnoli, E; Latteri, F; Biancofiore, G; Abbadessa, G; Morenghi, E; Santoro, A
Minidose warfarin prophylaxis for catheter-associated thrombosis in cancer patients: Can it be safely associated with fluorouracil-based chemotherapy?
2003-01-01 Masci, G; Magagnoli, M; Zucali, Pa; Castagna, L; Carnaghi, C; Sarina, B; Pedicini, V; Fallini, M; Santoro, A
Analysis of epidermal growth factor receptor expression as a predictive factor for response to gefitinib ('Iressa', ZD1839) in non-small-cell lung cancer
2004-01-01 Parra, Hs; Cavina, R; Latteri, F; Zucali, Pa; Campagnoli, E; Morenghi, E; Grimaldi, Gc; Roncalli, M; Santoro, A
Uncommon manifestations of common malignancies - Case 1. Soft-tissue metastases from malignant pleural mesothelioma
2004-01-01 Parra, Hs; Zucali, Pa; Colombo, P; Balzarini, L; Santoro, A
Activity of a specific inhibitor, gefitinib (Iressa, ZD1839), of epidermal growth factor receptor in refractory non-small-cell lung cancer
2004-01-01 Santoro, A.; Cavina, R.; Latteri, F.; Zucali, P. A.; Ginanni, V.; Campagnoli, E.; Ferrari, B.; Morenghi, E.; Pedicini, V.; Roncalli, M.; Alloisio, M.; Ravasi, G.; Soto Parra, H. J.
Positron emission tomography with F18-fluorodeoxyglucose (FDG-PET) in malignant pleural mesothelioma (MPM): Prediction of response to chemotheraphy by quantitative assessment of standard uptake value (SUV)
2005-01-01 Ceresoli, G; Zucali, P; Van Hemert, R; Cavina, R; De Vincenzo, F; Campagnoli, F; Tadayyon, S; Lutman, R; Chiti, A; Santoro, A
Short-schedule cisplatin andvinorelbine as induction chemotherapy in stage IIIA(N2)-IIIB non small cell lung cancer (NSCLC)
2005-01-01 Garassino, I.; Cavina, R.; Zucali, P. A.; Campagnoli, E.; De Vincenzo, F.; Parra H., Soto; Alloisio, M; Ceresoli, G. L.; Santoro, A.
Positron emission tomography with F18-fluorodeoxyglucose (FDG-PET) in malignant pleural mesothelioma (MPM): Evaluation of response to chemotherapy by quantitative assessment of standardized uptake value (SUV)
2005-01-01 Ceresoli, Gl; Chiti, A; Zucali, Pa; Cavina, R; De Vincenzo, F; Campagnoli, E; Garassino, I; Tadayyon, S; Rodari, M; Lutman, Rf; Alloisio, M; Santoro, A
Prophylaxis of central venous catheter-related thrombosis with minidose warfarin: Analysis of its use in 427 cancer patients
2005-01-01 Magagnoli, M; Masci, G; Castagna, L; Zucali, Pa; Morenghi, E; Pedicini, V; Santoro, A
Stage IIIA(N2)-IIIB non small cell lung cancer (NSCLC): Short-schedule cisplatin and vinorelbine as induction chemotherapy
2005-01-01 Zucali, P; Cavina, R; Parra, Hs; Campagnoli, E; De Vincenzo, F; Garassino, I; Alloisio, M; Balzarini, L; Ceresoli, G; Santoro, A
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Can sentinel node biopsy avoid axillary dissection in clinically node-negative breast cancer patients? | 1-gen-1998 | Galimberti, V.; Zurrida, S.; Zucali, P.; Luini, A. | |
Particle beam therapy (hadrontherapy): basis for interest and clinical experience | 1-gen-1998 | Orecchia, R; Zurlo, A; Loasses, A; Krengli, M; Tosi, G; Zurrida, S; Zucali, P; Veronesi, U | |
Optimized sentinel node scintigraphy in breast cancer | 1-gen-1998 | Paganelli, G; De Cicco, C; Cremonesi, M; Prisco, G; Calza, P; Luini, A; Zucali, P; Veronesi, U | |
[Combination of 5-Fluorouracil and folinic acid--is it still the standard therapy for advanced colorectal carcinoma?] | 1-gen-2000 | Carnaghi, C; Zucali, P; Garassino, I | |
Is combination of 5-FU/FA still the standard therapy for the treatment of advance colorectal cancer? | 1-gen-2000 | Carnaghi, C; Zucali, P; Garassino, I | |
Carcinoma del colon-retto | 1-gen-2001 | Zucali, PAOLO ANDREA; Rimassa, Lorenza; Santoro, Armando | |
Carcinoma del pancreas | 1-gen-2001 | Rimassa, Lorenza; Zucali, PAOLO ANDREA | |
Timing of breast cancer surgery in relation to the menstrual cycle: an update of developments | 1-gen-2001 | Zurrida, Stefano; Galimberti, Viviana; Gibelli, Bianca; Luini, Alberto; Gianoglio, Simona; Sandri, Maria Teresa; Passerini, Rita; Maisonneuve, Patrick; Zucali, Paolo; Jeronesi, Giulia; Pigatto, Francesca; Veronesi, Umberto | |
Irinotecan and raltitrexed: an active combination in advanced colorectal cancer | 1-gen-2002 | Carnaghi, C; Rimassa, L; Garassino, I; Zucali, Pa; Masci, G; Fallini, M; Morenghi, E; Santoro, A | |
Minidose warfarin is associated with a high incidence of International Normalized Ratio elevation during chemotherapy with FOLFOX regimen | 1-gen-2003 | Magagnoli, M; Masci, G; Carnaghi, C; Zucali, Pa; Castagna, L; Morenghi, E; Santoro, A | |
Gefitinib ('Iressa', ZD1839) in elderly patients with progressive pretreated non-small-cell lung cancer: results from the Istituto Clinico Humanitas | 1-gen-2003 | Parra, Hs; Cavina, R; Zucali, P; Campagnoli, E; Latteri, F; Biancofiore, G; Abbadessa, G; Morenghi, E; Santoro, A | |
Minidose warfarin prophylaxis for catheter-associated thrombosis in cancer patients: Can it be safely associated with fluorouracil-based chemotherapy? | 1-gen-2003 | Masci, G; Magagnoli, M; Zucali, Pa; Castagna, L; Carnaghi, C; Sarina, B; Pedicini, V; Fallini, M; Santoro, A | |
Analysis of epidermal growth factor receptor expression as a predictive factor for response to gefitinib ('Iressa', ZD1839) in non-small-cell lung cancer | 1-gen-2004 | Parra, Hs; Cavina, R; Latteri, F; Zucali, Pa; Campagnoli, E; Morenghi, E; Grimaldi, Gc; Roncalli, M; Santoro, A | |
Uncommon manifestations of common malignancies - Case 1. Soft-tissue metastases from malignant pleural mesothelioma | 1-gen-2004 | Parra, Hs; Zucali, Pa; Colombo, P; Balzarini, L; Santoro, A | |
Activity of a specific inhibitor, gefitinib (Iressa, ZD1839), of epidermal growth factor receptor in refractory non-small-cell lung cancer | 1-gen-2004 | Santoro, A.; Cavina, R.; Latteri, F.; Zucali, P. A.; Ginanni, V.; Campagnoli, E.; Ferrari, B.; Morenghi, E.; Pedicini, V.; Roncalli, M.; Alloisio, M.; Ravasi, G.; Soto Parra, H. J. | |
Positron emission tomography with F18-fluorodeoxyglucose (FDG-PET) in malignant pleural mesothelioma (MPM): Prediction of response to chemotheraphy by quantitative assessment of standard uptake value (SUV) | 1-gen-2005 | Ceresoli, G; Zucali, P; Van Hemert, R; Cavina, R; De Vincenzo, F; Campagnoli, F; Tadayyon, S; Lutman, R; Chiti, A; Santoro, A | |
Short-schedule cisplatin andvinorelbine as induction chemotherapy in stage IIIA(N2)-IIIB non small cell lung cancer (NSCLC) | 1-gen-2005 | Garassino, I.; Cavina, R.; Zucali, P. A.; Campagnoli, E.; De Vincenzo, F.; Parra H., Soto; Alloisio, M; Ceresoli, G. L.; Santoro, A. | |
Positron emission tomography with F18-fluorodeoxyglucose (FDG-PET) in malignant pleural mesothelioma (MPM): Evaluation of response to chemotherapy by quantitative assessment of standardized uptake value (SUV) | 1-gen-2005 | Ceresoli, Gl; Chiti, A; Zucali, Pa; Cavina, R; De Vincenzo, F; Campagnoli, E; Garassino, I; Tadayyon, S; Rodari, M; Lutman, Rf; Alloisio, M; Santoro, A | |
Prophylaxis of central venous catheter-related thrombosis with minidose warfarin: Analysis of its use in 427 cancer patients | 1-gen-2005 | Magagnoli, M; Masci, G; Castagna, L; Zucali, Pa; Morenghi, E; Pedicini, V; Santoro, A | |
Stage IIIA(N2)-IIIB non small cell lung cancer (NSCLC): Short-schedule cisplatin and vinorelbine as induction chemotherapy | 1-gen-2005 | Zucali, P; Cavina, R; Parra, Hs; Campagnoli, E; De Vincenzo, F; Garassino, I; Alloisio, M; Balzarini, L; Ceresoli, G; Santoro, A |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile